v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in capital
Other additional paid in capital
Other additional paid in capital
Employee stock notes
Accumulated deficit
Accumulated other comprehensive loss
Foreign currency adjustments
Unrealized gain on foreign currency hedges, net of tax
Unrealized loss on interest rate hedges, net of tax
Net actuarial pension (loss) gain, net of tax
Balance at beginning of period at Dec. 31, 2024     $ 846   $ 769,737 $ (673) $ (20,353) $ (129,495)        
Balance at beginning of period (in shares) at Dec. 31, 2024     84,653,408                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     771,364                  
Shares issued for exercise/vesting of share-based compensation awards     $ 8   (4)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (86,437)                  
Shares surrendered for tax obligations for employee share-based transactions     $ (1)   (714)              
Amortization of share-based compensation         7,661              
Net loss $ (211,663)           (211,663)          
Foreign currency adjustments 62,656               $ 62,656      
Unrealized gain (loss) on foreign currency hedges, net of tax                   $ (803)    
Unrealized gain (loss) on interest rate hedges, net of tax                     $ 25  
Unrealized gain on commodity hedges, net of tax                     99  
Net actuarial pension (loss) gain, net of tax (204)                     $ (204)
Balance at period end (in shares) at Jun. 28, 2025   0                    
Balance at end of period at Jun. 28, 2025 477,122 $ 0 $ 853 $ 776,007 776,680 (673) (232,016) (67,722)        
Balance at period end (in shares) at Jun. 28, 2025     85,338,335                  
Balance at beginning of period at Mar. 29, 2025     $ 851   772,339 (673) (210,491) (109,887)        
Balance at beginning of period (in shares) at Mar. 29, 2025     85,217,425                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     152,290                  
Shares issued for exercise/vesting of share-based compensation awards     $ 2                  
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (31,380)                  
Shares surrendered for tax obligations for employee share-based transactions         (92)              
Amortization of share-based compensation         4,433              
Net loss (21,525)           (21,525)          
Foreign currency adjustments 41,843               41,843      
Unrealized gain (loss) on interest rate hedges, net of tax                     60  
Net actuarial pension (loss) gain, net of tax (185)                     (185)
Balance at period end (in shares) at Jun. 28, 2025   0                    
Balance at end of period at Jun. 28, 2025 $ 477,122 $ 0 $ 853 776,007 776,680 (673) (232,016) (67,722)        
Balance at period end (in shares) at Jun. 28, 2025     85,338,335                  
Balance at beginning of period (in shares) at Dec. 31, 2025 0                      
Balance at beginning of period at Dec. 31, 2025 $ 92,216   $ 854   783,988 (673) (641,562) (50,391)        
Balance at beginning of period (in shares) at Dec. 31, 2025 85,489,683   85,489,683                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     1,210,663                  
Shares issued for exercise/vesting of share-based compensation awards     $ 12   (7)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (89,966)                  
Shares surrendered for tax obligations for employee share-based transactions     $ (1)   (243)              
Reclassification of share-based awards to liability         (90)              
Amortization of share-based compensation         5,941              
Net loss $ (108,384)           (108,384)          
Foreign currency adjustments (13,226)               (13,226)      
Unrealized gain (loss) on foreign currency hedges, net of tax                   $ 84    
Unrealized gain (loss) on interest rate hedges, net of tax                     $ 41  
Net actuarial pension (loss) gain, net of tax $ (212)                     (212)
Balance at period end (in shares) at Jun. 27, 2026 0 0                    
Balance at end of period at Jun. 27, 2026 $ (23,869) $ 0 $ 865 788,916 789,589 (673) (749,946) (63,704)        
Balance at period end (in shares) at Jun. 27, 2026 86,610,380   86,610,380                  
Balance at beginning of period at Mar. 28, 2026     $ 860   787,345 (673) (718,406) (56,945)        
Balance at beginning of period (in shares) at Mar. 28, 2026     86,120,743                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     495,778                  
Shares issued for exercise/vesting of share-based compensation awards     $ 5   (2)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (6,141)                  
Shares surrendered for tax obligations for employee share-based transactions         (13)              
Amortization of share-based compensation         2,259              
Net loss $ (31,540)           (31,540)          
Foreign currency adjustments (6,537)               $ (6,537)      
Net actuarial pension (loss) gain, net of tax $ (222)                     $ (222)
Balance at period end (in shares) at Jun. 27, 2026 0 0                    
Balance at end of period at Jun. 27, 2026 $ (23,869) $ 0 $ 865 $ 788,916 $ 789,589 $ (673) $ (749,946) $ (63,704)        
Balance at period end (in shares) at Jun. 27, 2026 86,610,380   86,610,380